Dr. Heath Devin Skinner's lab at the University of Pittsburgh focuses on improving treatment outcomes for head and neck cancer, particularly by understanding how the protein p16 influences cancer cell responses to radiation therapy. Their research aims to identify molecular pathways that can lead to better precision medicine approaches, helping to determine which patients are likely to respond to specific treatments. By using advanced models and innovative techniques, the lab hopes to enhance therapeutic strategies and improve the quality of life for cancer survivors.

Dr. Jon P. Boyle's lab at the University of Pittsburgh focuses on understanding how the placenta interacts with the teratogenic pathogen Toxoplasma gondii, which can cause significant harm to fetuses if transmitted during pregnancy. The lab investigates the cellular and molecular mechanisms behind the placental resistance to this pathogen and aims to find predictive markers for infection outcomes. By conducting experiments on placental cells and analyzing immune responses in pregnant women, the research seeks to improve our understanding of congenital toxoplasmosis and maternal-fetal health.

David Vorp's lab focuses on innovative approaches to regenerative medicine, using advanced techniques to attach extracellular vesicles (EVs) to biomaterials like silk for tissue repair. Their research aims to harness these natural signals from stem cells to improve healing and support the development of new treatments for chronic wounds and other medical applications. By collaborating with industry partners, they aim to make these technologies more accessible for clinical use.

Dr. Anthony A Grace's lab at the University of Pittsburgh explores how early stress impacts brain function differently in males and females. By studying rats, the lab examines how stress during critical developmental periods can lead to long-lasting changes in brain circuitry and behavior. The research aims to understand the mechanisms behind these differences to improve early interventions for psychiatric disorders that can develop later in life.

Dr. George C. Tseng's lab focuses on improving cancer research by developing methods to evaluate and select the best laboratory models that mimic real human tumors. Using advanced techniques like single-cell RNA sequencing, the lab aims to understand the diversity within tumors and how this affects treatment responses. Their work is crucial for advancing precision medicine and optimizing cancer therapies.

Dr. Gary Thomas's lab at the University of Pittsburgh is focused on understanding how specific genetic mutations impact neuronal function and behavior. By studying disorders linked to mutations in the PACS1 and PACS2 genes, the lab aims to unravel the cellular mechanisms that lead to neurodevelopmental issues like intellectual disability, epilepsy, and autism. This research could pave the way for developing new therapies for these debilitating conditions.

Dr. Gelsy Torres-Oviedo's lab at the University of Pittsburgh focuses on understanding how cognitive factors influence walking, especially in older adults at risk for Alzheimer's Disease. They investigate how gait—the way we walk—changes when our brains need to pay attention, and how this might indicate risks for cognitive decline. By studying the underlying brain mechanisms involved, the lab aims to improve early detection of Alzheimer's and related conditions.

Dr. Michael S Gold's lab focuses on understanding the mechanisms behind pain caused by injuries to the trigeminal nerve, which is a critical nerve responsible for sensation in the face. They investigate how this type of nerve injury differs from others in terms of its response and treatment. The lab's ultimate goal is to identify more effective therapies for alleviating pain associated with trigeminal nerve injuries by exploring changes at the molecular level, particularly with certain proteins that could be targeted for treatment.

Dr. Joanne L. Flynn's lab focuses on improving the efficacy of vaccines against tuberculosis (TB), a major global health concern. The lab investigates new strategies to enhance the immune response to the BCG vaccine using modern techniques and animal models. Their research aims to better understand how to protect against TB and identify key markers of vaccine effectiveness.

Dr. Charles A. Scanga's lab at the University of Pittsburgh focuses on improving tuberculosis (TB) vaccines, particularly for HIV-infected children. The research explores new delivery methods and vaccine strains to enhance safety and effectiveness. Using animal models, the lab aims to better understand immune responses to TB vaccines and how these can be optimized for vulnerable populations.

Dr. Bennett Van Houten's lab at the University of Pittsburgh focuses on understanding how DNA repair proteins work together to protect the genome from damage caused by environmental factors. Using advanced imaging techniques and biochemical methods, the team studies the interactions between various DNA repair proteins and their role in different cellular contexts. The ultimate goal is to uncover the mechanisms of DNA repair, which can have implications for diseases like cancer and neurodegeneration.

Dr. Kejie Yin's research lab at the University of Pittsburgh focuses on better understanding vascular cognitive impairment and dementia (VCID), which is a significant cause of dementia following Alzheimer's disease. The lab studies how certain proteins and long non-coding RNAs (like KLF11 and Malat1) influence brain health, particularly in relation to blood flow to the brain and the integrity of brain structures. The ultimate goal of this research is to develop new therapies to improve cognitive function and protect against brain injuries associated with VCID.

Dr. Qiming Jane Wang's lab focuses on developing innovative treatments for advanced castration-resistant prostate cancer (aCRPC). The research combines targeted therapies that inhibit specific cancer cell regulators, using nanocarrier technology to deliver these drugs directly to tumors. The aim is to enhance treatment effectiveness while minimizing side effects, which is crucial for improving patient outcomes in aggressive forms of prostate cancer.

Dr. Zongqi Xia's research lab focuses on improving treatment strategies for multiple sclerosis by utilizing electronic health records (EHR). They aim to tailor treatments to individual patients based on real-world data and computational methods. This innovative approach will help identify the most effective therapies and optimize treatment sequences for better patient outcomes.

Dr. Wen Xie's lab focuses on understanding how environmental chemicals affect human health through their interactions with xenobiotic receptors. These receptors help regulate the metabolism of harmful substances in the body, potentially preventing chronic illnesses such as liver disease and neurological disorders. The research aims to uncover the mechanisms behind these interactions and find ways to mitigate their negative effects on health.